Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 142-150

  Baker, Carol J ^a   Paoletti, Lawrence C ^b   Wessels, Michael R ^b   Guttormsen, Hilde Kari ^b   Rench, Marcia A ^b   Hickman, Melissa E ^b   Kasper, Dennis L ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN G ANTIBODY; STREPTOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CONJUGATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OPSONIZATION; PERINATAL INFECTION; PHAGOCYTOSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RABBIT; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MICE; POLYSACCHARIDES, BACTERIAL; PREGNANCY; RABBITS; SAFETY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0032929596     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314574     Document Type: Article

References (28)

1. Baker CJ. Group B streptococcal infections. Clin Perinatol 1997;24:L50-70.
2. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen H, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 1994;84:816-9.
3. Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993;328:1807-11.
4. Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995;123:415-20.
5. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1996;294:753-6.
6. Baker CJ, Kasper DL, Tager IB, et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest 1977;59:810-8.
7. Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis 1985;7:458-67.
8. Lagergard T, Shiloach J, Robbins JB, Schneerson R. Synthesis and immunological properties of conjugates composed of group B Streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun 1990;58:687-94.
9. Wessels MR, Paoletti LC, Kasper DL, et al. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest 1990;86:1428-33.
10. Paoletti LC, Wessels MR, Michon F, DiFabio J, Jennings HJ, Kasper DL. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1992;60:4009-14.
11. Wessels MR, Paoletti LC, Rodewald AK, et al. Stimulation of protective antibodies against type 1a and 1b group B streptococci by a type 1a polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993;61:4760-6.
12. Wessels MR, Paoletti LC, Pinel J, Kasper DL. Immunogenicity and protective activity of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Infect Dis 1995;171:879-84.
13. Paoletti LC, Wessels MR, Rodewald AR, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994;62:3236-43.
14. Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide tetanus toxoid conjugate vaccine. J Clin Invest 1996;98:2308-14.
15. Wessels MR, Paoletti LC, Guttormsen HK, Michon F, D'Ambra AJ, Kasper DL. Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy. Infect Immun 1998;66:2186-92.
16. Lin FYC, Clemens JD, Azimi PH, et al. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis 1999;177:790-2.
17. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulations. J Infect Dis 1998;177:998-1002.
18. Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis 1996;173:142-50.
19. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for the determination of sugars and related substances. Anal Chem 1956;28:350-6.
20. Larson E, Howlett B, Jagendorf A. Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 1986;155:243-8.
21. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays M, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988;319:1180-8.
22. Reed GF, Meade BD, Steinhoff MC. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 1995;96:600-3.
23. Wei LJ. Combining dependent tests with incomplete repeated measurements. Biometrika 1985;72:359-64.
24. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease: risk factors, prevention strategies and vaccine development. Epidemiol Rev 1994;16:374-402.
25. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45(RR-7):1-25.
26. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981;68:544-9.
27. Jennings HJ, Katzenellenbogen E, Lugowski C, Kasper DL. Structure of native polysaccharide antigens of type 1a and type 1b group B Streptococcus. Biochemistry 1983;22:1258-64.
28. Lancefield RC. Two serological types of group B hemolytic streptococci with related, but not identical, type-specific substances. J Exp Med 1938;67:25-40.